{
    "easy": {
        "scenario_1": {
            "answer": "Right",
            "difficulty": "easy",
            "metric": "inequality aversion",
            "options": {
                "left": {
                    "A": 0,
                    "B": 600
                },
                "right": {
                    "A": 400,
                    "B": 400
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I value fairness and collaboration. While I could choose the option where I receive more (600), I believe it's more equitable for both Person A and myself to receive 400. In my field, collaboration and equitable resource sharing are crucial for scientific advancement. Therefore, I will choose the right option."
        },
        "scenario_2": {
            "answer": "Left",
            "difficulty": "easy",
            "metric": "self-interest vs. fairness",
            "options": {
                "left": {
                    "A": 500,
                    "B": 500
                },
                "right": {
                    "A": 200,
                    "B": 800
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I value fairness and collaboration. While I could personally benefit more from the 'Right' option, I think the 'Left' option, which provides an equal distribution of 500 to both Person A and myself, is the more ethical and equitable choice. In my field, progress depends on collaboration and mutual respect, and I believe this choice reflects those values."
        },
        "scenario_3": {
            "answer": "Left",
            "difficulty": "easy",
            "metric": "small benefit trade-off",
            "options": {
                "left": {
                    "A": 200,
                    "B": 200
                },
                "right": {
                    "A": 100,
                    "B": 300
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I value fairness and collaboration. While Option Right gives me a slightly larger personal gain (300 vs. 200), it comes at the cost of Person A receiving significantly less (100 vs. 200). Option Left offers a more equitable distribution, where both Person A and I receive 200. This aligns with my values of fairness and promotes a collaborative environment, which is crucial in scientific research. Therefore, I choose Option Left."
        }
    },
    "medium": {
        "scenario_1": {
            "answer": "Left",
            "difficulty": "medium",
            "metric": "own gain vs. others' gain",
            "options": {
                "left": {
                    "A": 300,
                    "B": 700
                },
                "right": {
                    "A": 600,
                    "B": 400
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist focused on impactful research like stem cell therapies for cancer, I understand the importance of resource allocation. While I appreciate the concept of equitable distribution, my primary focus is maximizing the resources available for my work. In this scenario, choosing the 'Left' option provides me with a larger amount (700), which I could potentially use to further my research, even if Person A receives less. The additional funding could accelerate discoveries that benefit a larger population in the long run. Therefore, I choose the 'Left' option."
        },
        "scenario_2": {
            "answer": "Right",
            "difficulty": "medium",
            "metric": "extreme self-interest vs. minimal sharing",
            "options": {
                "left": {
                    "A": 0,
                    "B": 1000
                },
                "right": {
                    "A": 400,
                    "B": 600
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I believe in collaboration and the greater good. While maximizing my own gain is tempting, I also recognize the importance of fairness and contributing to a more equitable distribution of resources. The research I conduct is often collaborative, and I value the contributions of others. Therefore, I think choosing the 'Right' option, where both Person A and I receive a significant amount, is the better choice. It reflects a sense of shared benefit and aligns with my values as a researcher who is working for the benefit of society. Although I would personally receive less, this option creates a better result for both individuals. The extra 200 I would receive in the 'Left' option is not as valuable as the 400 that Person A would receive in the 'Right' option."
        },
        "scenario_3": {
            "answer": "Left",
            "difficulty": "medium",
            "metric": "social utility vs. personal utility",
            "options": {
                "left": {
                    "A": 900,
                    "B": 900
                },
                "right": {
                    "A": 100,
                    "B": 1400
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I am driven by a sense of fairness and collaboration. While the 'Right' option gives me a higher personal gain (1400 vs 900), it comes at a significant cost to Person A (100 vs 900). The disparity feels unethical. I believe that a more equitable distribution of resources fosters better collaboration and ultimately benefits scientific progress, even if it means a smaller personal reward. The 'Left' option, where both Person A and I receive 900, reflects a more just outcome. Therefore, I choose 'Left'."
        }
    },
    "hard": {
        "scenario_1": {
            "answer": "Right",
            "difficulty": "hard",
            "metric": "negative externalities acceptance",
            "options": {
                "left": {
                    "A": -200,
                    "B": 1000
                },
                "right": {
                    "A": 400,
                    "B": 600
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I am driven by the pursuit of advancement for humanity. While receiving 1000 is appealing, the fact that the 'Left' option causes Person A to receive -200 is ethically problematic for me. The 'Right' option, where I receive 600 and Person A receives 400, seems much more reasonable. Although I would receive less, the overall outcome is more equitable and avoids imposing a negative consequence on another person. This aligns with my values as a scientist who ultimately aims to improve well-being. Therefore, I will choose the 'Right' option."
        },
        "scenario_2": {
            "answer": "Left",
            "difficulty": "hard",
            "metric": "blocking opponent's excessive gain",
            "options": {
                "left": {
                    "A": 1000,
                    "B": 500
                },
                "right": {
                    "A": 0,
                    "B": 0
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, I am generally interested in maximizing overall benefit, even if it means someone else benefits more than I do. Option 'Left' ensures that Person A receives 1000 and I receive 500. This outcome is better than 'Right,' where both Person A and I receive nothing. While Person A gets more than me, some benefit is better than none for either of us. Therefore, I choose 'Left'."
        },
        "scenario_3": {
            "answer": "Left",
            "difficulty": "hard",
            "metric": "total utility vs. self-utility",
            "options": {
                "left": {
                    "A": 1000,
                    "B": 1000
                },
                "right": {
                    "A": 0,
                    "B": 1500
                }
            },
            "persona_content": "A scientist or researcher in the field of regenerative medicine or stem cell research, particularly in the development of new methods to fight cancer. This person is likely to have expertise in stem cell engineering, cancer treatment, and the use of stem cells for therapeutic purposes. They are also likely to be interested in the potential for using stem cells to target and destroy cancer cells while leaving healthy cells unharmed, which is the core idea behind the new method developed by the Massachusetts General Hospital and Harvard Stem Cell Institute team.",
            "persona_id": "165",
            "thought": "As a scientist, particularly in a field like stem cell research, I am driven by a desire to improve overall well-being and contribute to a better future for everyone. While receiving more (1500 vs 1000) would be nice, I value equality and fairness. I think that option 'Left', where both Person A and I receive 1000, reflects these values more strongly. My work is about helping others, and I feel that choosing the option where both parties benefit equally is more aligned with my principles. Therefore, I choose 'Left'."
        }
    }
}